Published in Br J Psychiatry on August 01, 1999
Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry (2014) 1.39
Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. J Anxiety Disord (2007) 1.05
Social anxiety disorder in childhood and adolescence: current status and future directions. Clin Child Fam Psychol Rev (2001) 1.03
A Proposed Algorithm for Improved Recognition and Treatment of the Depression/Anxiety Spectrum in Primary Care. Prim Care Companion J Clin Psychiatry (2001) 0.94
Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial. Psychopharmacology (Berl) (2004) 0.90
Efficacy and tolerability of second-generation antidepressants in social anxiety disorder. Int Clin Psychopharmacol (2008) 0.90
Evaluation of anxiolytic potency of essential oil and S-(+)-linalool from Cinnamomum osmophloeum ct. linalool leaves in mice. J Tradit Complement Med (2014) 0.86
Anxiety Disorders in Neurologic Illness. Curr Treat Options Neurol (2001) 0.84
The efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating Scales. PLoS One (2014) 0.83
Optimal treatment of social phobia: systematic review and meta-analysis. Neuropsychiatr Dis Treat (2012) 0.83
Social fear conditioning: a novel and specific animal model to study social anxiety disorder. Neuropsychopharmacology (2012) 0.80
Social Anxiety Disorder: More Than Just a Little Shyness. Prim Care Companion J Clin Psychiatry (2001) 0.80
INFLUENCE OF STUDY DESIGN ON TREATMENT RESPONSE IN ANXIETY DISORDER CLINICAL TRIALS. Depress Anxiety (2015) 0.78
Paroxetine for somatic pain associated with physical illness: a review. Prim Care Companion J Clin Psychiatry (2006) 0.78
Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials. Psychopharmacology (Berl) (2010) 0.77
Resistant social anxiety disorder response to Escitalopram. Clin Pract Epidemiol Ment Health (2006) 0.77
Toward an integrative understanding of social phobia. J Psychiatry Neurosci (2001) 0.75
Authorship of clinical trial reports. Br J Psychiatry (2000) 0.75
Post-Marketing Surveillance of Fluvoxamine Maleate Used Long-Term in Patients with Social Anxiety Disorder in Japan. Drugs Real World Outcomes (2014) 0.75
Psychopharmacology of anxiety disorders. Dialogues Clin Neurosci (2002) 0.75
Clinical presentation and pharmacotherapy response in social anxiety disorder: The effect of etiological beliefs. Psychiatry Res (2015) 0.75
What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychol Med (2010) 4.33
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry (2008) 3.81
Twelve-month mental disorders in South Africa: prevalence, service use and demographic correlates in the population-based South African Stress and Health Study. Psychol Med (2007) 2.55
Self-disclosure of HIV serostatus in recently diagnosed patients with HIV in South Africa. Afr J Reprod Health (2004) 2.31
Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord (2007) 2.12
Domestic violence in patients visiting general practitioners--prevalence, phenomenology, and association with psychopathology. S Afr Med J (1999) 1.92
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry (2001) 1.86
Trichobezoars in trichotillomania: case report and literature overview. Psychosom Med (1998) 1.69
Trichotillomania: behavioral symptom or clinical syndrome? Am J Psychiatry (1997) 1.63
Porokeratosis and immunosuppression. Eur J Dermatol (1999) 1.62
Post-traumatic stress disorder among recently diagnosed patients with HIV/AIDS in South Africa. AIDS Care (2005) 1.60
Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry (1995) 1.57
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Are musical obsessions a temporal lobe phenomenon? J Neuropsychiatry Clin Neurosci (1999) 1.56
Association of panic disorder with a history of traumatic suffocation. Am J Psychiatry (1997) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Eating disorder and superior mesenteric artery syndrome. J Am Acad Child Adolesc Psychiatry (2000) 1.52
Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa. AIDS Patient Care STDS (2004) 1.50
Mental health and sexual risk behaviours in a South African township: a community-based cross-sectional study. Public Health (2006) 1.50
A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc (1991) 1.49
The role of genetic variability in the SLC6A4, BDNF and GABRA6 genes in anxiety-related traits. Acta Psychiatr Scand (2011) 1.48
Violence in male patients with schizophrenia: risk markers in a South African population. Aust N Z J Psychiatry (2004) 1.47
Povidone iodine and skin disinfection before initiation of epidural anesthesia. Anesthesiology (1998) 1.44
Trauma exposure and post-traumatic stress symptoms in urban African schools. Survey in CapeTown and Nairobi. Br J Psychiatry (2004) 1.43
Characteristics and phenomenology of hair-pulling: an exploration of subtypes. Compr Psychiatry (2001) 1.40
Maternal separation in rats leads to anxiety-like behavior and a blunted ACTH response and altered neurotransmitter levels in response to a subsequent stressor. Metab Brain Dis (2004) 1.40
[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40
'Sleep therapy' or medical malpractice? S Afr Med J (1997) 1.39
[Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Ann Dermatol Venereol (1999) 1.39
Clinical picture: eyelid metastasis. Lancet (2001) 1.39
Selective serotonin reuptake inhibitors in children and adolescents. S Afr Med J (2006) 1.38
Determinants of unprotected sex among HIV-positive patients in South Africa. AIDS Care (2005) 1.36
Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry (1998) 1.36
Twelve-month treatment of psychiatric disorders in the South African Stress and Health Study (World Mental Health Survey Initiative). Soc Psychiatry Psychiatr Epidemiol (2008) 1.32
The Truth and Reconciliation Commission in South Africa: relation to psychiatric status and forgiveness among survivors of human rights abuses. Br J Psychiatry (2001) 1.26
Immunohistochemical study of CD34-positive dendritic cells of human dermis. Am J Dermatopathol (1996) 1.25
A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry (1997) 1.19
In Xenopus laevis, the product of a developmentally regulated mRNA is structurally and functionally homologous to a Saccharomyces cerevisiae protein involved in translation fidelity. Mol Cell Biol (1993) 1.18
Autism and family home movies: preliminary findings. J Autism Dev Disord (1991) 1.16
Vasopressin and angiotensin II receptors in rat aortic smooth muscle cells in culture. Am J Physiol (1983) 1.16
Validity of the K-10 in detecting DSM-IV-defined depression and anxiety disorders among HIV-infected individuals. AIDS Care (2009) 1.14
Obsessive-compulsive and spectrum disorders: overview and quality of life issues. J Clin Psychiatry (1996) 1.13
Gi2-mediated activation of the MAP kinase cascade. Mol Biol Cell (1995) 1.12
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase. Proc Natl Acad Sci U S A (2001) 1.10
Interactions of proteins and lipids: structure and polymorphism of protein-lipid-water phases. Nature (1969) 1.09
Psychological treatments for depression and anxiety disorders in low- and middle- income countries: a meta-analysis. Afr J Psychiatry (Johannesbg) (2011) 1.08
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev (2006) 1.08
Gender differences in the prevalence of childhood sexual abuse and in the development of pediatric PTSD. Arch Womens Ment Health (2004) 1.07
Hypervigilance for fear after basolateral amygdala damage in humans. Transl Psychiatry (2012) 1.06
Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol Rev (2001) 1.06
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
The effects of co-morbidity on the onset and persistence of generalized anxiety disorder in the ICPE surveys. International Consortium in Psychiatric Epidemiology. Psychol Med (2002) 1.04
Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder. J Clin Psychiatry (1999) 1.04
Olfactory reference syndrome: diagnostic criteria and differential diagnosis. J Postgrad Med (2003) 1.03
Comparative morphology and paleobiology of Middle Pleistocene human remains from the Bau de l'Aubesier, Vaucluse, France. Proc Natl Acad Sci U S A (2001) 1.02
Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety (2000) 1.02
Quality of life in the anxiety disorders. Harv Rev Psychiatry (2000) 1.02
Functional magnetic resonance imaging during emotion recognition in social anxiety disorder: an activation likelihood meta-analysis. Front Hum Neurosci (2013) 1.02
Re-emergence of brucellosis in cattle in France and risk for human health. Euro Surveill (2012) 1.00
Mild hypothermia: therapeutic window after experimental cerebral ischemia. Neurosurgery (1996) 1.00
Specificity of neuropsychological impairment in obsessive-compulsive disorder: a comparison with social phobic and normal control subjects. J Neuropsychiatry Clin Neurosci (1996) 1.00
Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol (1999) 0.99
Maternal separation alters nerve growth factor and corticosterone levels but not the DNA methylation status of the exon 1(7) glucocorticoid receptor promoter region. Metab Brain Dis (2009) 0.99
Identification of a human guanine nucleotide-releasing factor (H-GRF55) specific for Ras proteins. Oncogene (1993) 0.99
The mental health impact of AIDS-related mortality in South Africa: a national study. J Epidemiol Community Health (2008) 0.99
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry (2001) 0.98
Obsessive-compulsive disorder with poor insight. Compr Psychiatry (2002) 0.98
Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence. Eur Psychiatry (2005) 0.97
Cyclic nucleotide phosphodiesterase of Dictyostelium discoideum and its glycoprotein inhibitor: structure and expression of their genes. Dev Genet (1991) 0.97
The psychometric properties of the K10 and K6 scales in screening for mood and anxiety disorders in the South African Stress and Health study. Int J Methods Psychiatr Res (2011) 0.96
In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations. Clin Exp Immunol (1982) 0.96
Translation and cross-cultural adaptation of a mental health battery in an African setting. Afr Health Sci (2006) 0.95
[Predictive validity of the Scale of Prodromal Symptoms (SOPS)]. Actas Esp Psiquiatr (2006) 0.95
Association between sexual violence and psychiatric morbidity among HIV positive women in South Africa. Afr J Med Med Sci (2006) 0.95
Validity of the Kessler 10 (K-10) in detecting DSM-IV defined mood and anxiety disorders among pregnant women. Arch Womens Ment Health (2009) 0.94
Attitudes towards and beliefs about schizophrenia in Xhosa families with affected probands. Curationis (2002) 0.94
Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder. Am J Psychiatry (1995) 0.94
Explanatory models of mental disorders and treatment practices among traditional healers in Mpumulanga, South Africa. Afr J Psychiatry (Johannesbg) (2010) 0.94
Resting brain perfusion in social anxiety disorder: a voxel-wise whole brain comparison with healthy control subjects. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.94
Trauma and post-traumatic stress disorder in women: a review. Int Clin Psychopharmacol (2000) 0.94
Patterns of anxiety and personality disorder comorbidity. J Psychiatr Res (1996) 0.94
Mental health literacy: focus on developing countries. Afr J Psychiatry (Johannesbg) (2008) 0.93
Willingness to participate in HIV vaccine research in a peri-urban South African community. Int J STD AIDS (2006) 0.93
Quantitative evaluation of two distinct cell populations expressing HLA-DR antigens in normal human epidermis. Br J Dermatol (1984) 0.93
Fluvoxamine treatment of body dysmorphic disorder. J Clin Psychopharmacol (1994) 0.92
Augmentation of cognitive behavioral therapy with pharmacotherapy. Psychiatr Clin North Am (2010) 0.92
Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder. Int Clin Psychopharmacol (2001) 0.92
Sleep-EEG in borderline patients without concomitant major depression: a comparison with major depressives and normal control subjects. Psychiatry Res (2001) 0.92
Long-term survival and immunological tolerance of human epidermal allografts produced in culture. Transplantation (1986) 0.91
Land of promise: challenges and opportunities for research in South Africa. Mol Psychiatry (2004) 0.91
Brain glucose metabolism in borderline personality disorder. J Psychiatr Res (1998) 0.91
Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors? Int J Neuropsychopharmacol (2001) 0.91
Multiple eruptive dermatofibromas in a patient with HIV infection: case report and literature review. J Cutan Pathol (2000) 0.90
Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man. Cell Immunol (1984) 0.90
The cyclic nucleotide phosphodiesterase gene of Dictyostelium discoideum utilizes alternate promoters and splicing for the synthesis of multiple mRNAs. Mol Cell Biol (1989) 0.90
The reliability of three definitions of bizarre delusions. Am J Psychiatry (1993) 0.89